Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension

Current Hypertension Reports

Volumn 10, Issue 2, 2008, Pages 151-155

  Frohlich, Edward D ^a   Susic, Dinko ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE; CHIMERIN; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTAGLANDIN E2; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VISFATIN;

BLOOD PRESSURE REGULATION; BLOOD VOLUME; COMORBIDITY; CORONARY HEMODYNAMICS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; EXERCISE; HEART OUTPUT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY BLOOD FLOW; MEAN ARTERIAL PRESSURE; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VENOUS RETURN; WEIGHT REDUCTION; BLOOD PRESSURE; HEMODYNAMICS; HYPERTENSION; KIDNEY; VASCULARIZATION;

BLOOD PRESSURE; HEMODYNAMICS; HUMANS; HYPERTENSION; KIDNEY; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 52049125531     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-008-0028-8     Document Type: Review

References (56)

1. Kannel WB, Dawber TR, Kagen A, et al.: Factors of risk in the development of coronary heart disease: six years' follow-up experience. Ann Intern Med 1961, 55:33-50.
2. Rahmouni K, Correia MLG, Haynes WG, Mark AL: Obesity-associated hypertension. New insights into mechanisms. Hypertension 2005, 45:9-14.
3. Praga M, Morales E: Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 2006, 15:481-486.
4. Poirier P, Giles TD, Bray GA, et al.; American Heart Association; Obesity Committee of the Council of Nutrition, Physical Activity, and Metabolism: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
5. Bosma RJ, Krikken JA, Homan van der Heide JJ, et al.: Obesity and renal hemodynamics. Contrib Nephrol 2006, 151:184-202.
6. Mayers MR, Gokce N: Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007, 14:365-365.
7. Kearney PM, Whelton M, Reynolds K, et al.: Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
8. Julius S, Valentini M, Palatini P: Overweight and hypertension: a 2-way street? Hypertension 2000, 35:807-813.
9. Kaltman AJ, Goldring RM: Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976, 60:645-653.
10. Sims EAH: Mechanisms of hypertension in overweight. Hypertension 1978, 4:43-49.
11. Messerli FH, Ventura HO, Reisin E, et al.: Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 1982, 66:55-60.
12. Raison J, Achimastos A, Bouthier J, et al.: Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol 1983, 51:165-170.
13. Mujais SK, Tarazi RC, Dustan HP, et al.: Hypertension in obese patients: Hemodynamic and volume studies. Hypertension 1982, 4:848-92.
14. Frohlich ED, Messerli FH, Reisin E, Dunn FG: The problem of obesity and hypertension. Hypertension 1983, 5:71-78.
15. Ku CS, Lin SL, Wang DJ, et al.: Left ventricular filling in young normotensive obese adults. Am J Cardiol 1994, 73:613-615.
16. Nussberger J: Investigating mineralocorticoid hypertension. J Hypertension 2003, 21(Suppl):S25-S30.
17. Frohlich ED, Tarazi RC, Dustan HP: Hemodynamic and functional mechanisms in two renal hypertensions: arterial and pyelonephritis. Am J Med Sci 1971, 261:189-195.
18. Preston RA, Singer I, Epstein M: Renal parenchymal hypertension: current concepts of pathogenesis and management. Arch Intern Med 1996, 156:602-611.
19. Frohlich ED: Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed Proc 1982, 41:2400-2408.
20. Messerli FH, Christie B, deCarvalho JG, et al.: Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med 1981, 141:81-85.
21. Frohlich ED: Hemodynamics and other determinants in development of left ventricular hypertrophy: conflicting factors in its regression. Fed Proc 1983, 42:2709-2715.
22. Kenchaiah S, Pfeffer MA: Cardiac remodeling in systemic hypertension. Med Clin North Am 2004, 88:115-130.
23. de Simone G, Pasanisi F, Contaldo F: Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001, 38:13-18.
24. Frohlich ED: The heart in hypertension: a 1991 overview. Hypertension 1991, 18:62-68.
25. Linzbach AJ: Heart failure from the point of view of quantitative anatomy. Am J Cardiol 1960, 5:370-382.
26. Messerli FH, Sundgaard-Riise K, Reisin E, et al.: Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 1983, 74:808-812.
27. Messerli FH, Sundgaard-Riise K, Reisin E, et al.: Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983, 99:757-761.
28. Lavie CJ, Milani RV, Ventura HO, et al.: Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007, 100:1460-1464.
29. Uretsky S, Messerli FH, Bangalore S, et al.: Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007, 120:863-870.
30. Reisin E, Messerli FH, Ventura H, Frohlich ED: Renal hemodynamic studies in obesity hypertension. J Hypertens 1987, 5:397-400.
31. Bosma RJ, van der Heide JJ, Oosterop EJ, et al.: Body mass index is associated with altered renal hemodynamics in non-obese healthy humans. Kidney Int 2004, 65:259-265.
32. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 1995, 26:610-615.
33. Scaglione R, Ganguzza A, Corrao S, et al.: Central obesity and hypertension: pathophysiologic role of renal hemodynamic and function. Int J Obes Relat Metab Disord 1995, 19:403-409.
34. Chagnac A, Weinstei T, Korzets A, et al.: Glomerular hemodynamics in severe obesity. Am J Physiol 2000, 278:F817-F822.
35. Schmitz PG, O'Donnell MP, Kasiske BL, et al.: Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 1992, 263:F496-F502.
36. Chagnac A, Weinstei T, Herman M, et al.: The effect of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003, 14:1480-1486.
37. Dengel DR, Goldberg AP, Mayaga RS, et al.: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996, 28:127-132.
38. Vaz M, Jennings G, Turner A, et al.:Regional sympathetic activity and oxygen consumption in obese normotensive human subjects. Circulation 1997, 96:3423-3429.
39. De Paula RB, Da Silva AA, Hall JE: Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 204:43:41-47.
40. Engeli S, Bohnke J, Gorzelniak K, et al.: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45:356-362.
41. Gelber RP, Kurth T, Kausz AT, et al.: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005, 46:871-880.
42. Hsu CY, McCulloch CE, Iribarren C, et al.: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006, 144:21-28.
43. Reisin E, Frohlich ED, Messerli FH, et al.: Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983, 98:315-319.
44. Morales E, Valero MA, Leon M, et al.: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41:319-327.
45. Praga M, Morales E: Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 2006, 15:481-486.
46. Sciacqua A, Candigliota M, Ceravolo R, et al.: Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003, 26:2119-2125.
47. Gokce N, Vita JA, McDonnell M, et al.: Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 2005, 95:266-268.
48. Wildman RP, Faarhat GN, Patel AS, et al.: Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 2005, 45:187-192.
49. Wunsch R, de Sousa G, Toschke AM, Reinehr T: Intimamedia thickness in obese children before and after weight loss. Pediatrics 2006, 118:2334-2340.
50. Engeli S, Bohnke J, Gorzelniak K, et al.: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45:356-362.
51. Cancello R, Henegar C, Viguerie N, et al.: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
52. Frohlich ED: Recent advances in hypertension, stroke, and cardiorenal disease. Curr Opin Cardiol 2005, 20:258-263.
53. Lau DCW, Bikramjit D, Yan H, et al.: Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol 2005, 288:H2031-H2041.
54. Kralisch S, Sommer G, Deckert CM, et al.: Adipokines in diabetes and cardiovascular disease. Minerva Endocrinol 2007, 32:161
55. Goralski KB, McCarthy TC, Hanniman EA, et al.: Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007, 282:28175-28188.
56. Fantuzzi G, Mazzone T: Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007, 27:996-1003.